COVID-19
US Senators Sherrod Brown (D-OH) and Brian Schatz (D-HI) led a bipartisan group of 11 senators in a letter to Johnson & Johnson, Pfizer, and Moderna, calling on the pharmaceutical giants to increase COVID-19 vaccine distribution to low- and middle-income countries. The senators' letter comes after a previous bipartisan
Pharmaceutical industry
The European Medicines Agency (EMA) has given the nod to the Novavax coronavirus vaccine, a protein-based shot that could be a game-changer in the fight against COVID-19. The vaccine, which uses a minuscule, look-alike version of the covid-19 spike protein, has proven to be safe and effective, with a 90.
COVID-19
Nine U.S. Senators, led by Ohio Senator Sherrod Brown and Hawaii Senator Brian Schatz, have called on Johnson & Johnson, Pfizer, and Moderna to increase COVID-19 vaccine production in low- and middle-income countries, citing the need to tackle the global disparities in vaccine access. The senators argue that if
COVID-19
The World Health Organization has released interim guidance on combining different COVID-19 vaccines for second doses and booster shots, citing varying levels of vaccine availability globally. According to the WHO, mRNA vaccines from Pfizer and Moderna can be used as subsequent doses after initial doses of AstraZeneca's vectored
COVID-19
The global precision medicine market is expected to grow from $62.75 billion in 2020 to $72.58 billion in 2021 at a compound annual growth rate (CAGR) of 15.7%. The market is driven by the rising prevalence of cancer and the development of novel precision medicines for pancreatic
Pharmaceutical industry
GlaxoSmithKline and Sanofi have announced positive results for their Covid-19 booster vaccine candidate, with consistently strong immune responses shown in a booster jab. The trial, the most comprehensive booster trial to date, explored boosting across different vaccine technologies used for primary vaccination. The companies plan to file the booster data
Pharmaceutical industry
The global multiple sclerosis (MS) drugs market is projected to grow from $21.27 billion in 2020 to $25.95 billion in 2025, driven by the increasing demand for effective treatments and the introduction of new products. The market is segmented by drug class, distribution channels, and route of administration.
COVID-19
The biosimilar therapeutic peptides market is witnessing significant growth due to the increasing demand for peptide-based drugs, which are used to treat a range of chronic diseases such as cancer, cardiovascular diseases, and respiratory conditions. The market is expected to reach $2.25 billion by 2025 at a CAGR of
COVID-19
Researchers from Sheba Medical Center in Tel-Hashomer, Israel, conducted a study to examine the immunogenicity and safety of the Pfizer-BioNTech COVID-19 vaccine in HSCT recipients. The study involved 152 patients who were at least six months post-transplantation and without active acute graft-versus-host disease (GVHD). The team collected blood samples from
Pharmaceutical industry
The global benign prostatic hyperplasia (BPH) treatment market was valued at $10.5 billion in 2020 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.6% from 2021 to 2026. The market is driven by the increasing prevalence of urological disorders, rising geriatric population, and
Pharmaceutical industry
The global benign prostatic hyperplasia (BPH) treatment market reached a value of US$ 10.5 Billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 5.6% during 2021-2026. The market is driven by the increasing prevalence of urological disorders, rising geriatric population, and
Vaccines
Global stock markets and oil prices plummeted yesterday after vaccine maker Moderna warned that existing jabs may be less effective against the new omicron variant of Covid-19. The company's chief executive, Stephane Bancel, predicted a significant drop in vaccine effectiveness and said it would take several months for
